INVO Fertility, Inc. (IVF) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
INVO Fertility, Inc. stock (IVF) is currently trading at $0.63. INVO Fertility, Inc. PS ratio (Price-to-Sales) is 0.69. Analyst consensus price target for IVF is $4.00. WallStSmart rates IVF as Sell.
- IVF PE ratio analysis and historical PE chart
- IVF PS ratio (Price-to-Sales) history and trend
- IVF intrinsic value — DCF, Graham Number, EPV models
- IVF stock price prediction 2025 2026 2027 2028 2029 2030
- IVF fair value vs current price
- IVF insider transactions and insider buying
- Is IVF undervalued or overvalued?
- INVO Fertility, Inc. financial analysis — revenue, earnings, cash flow
- IVF Piotroski F-Score and Altman Z-Score
- IVF analyst price target and Smart Rating
INVO Fertility, Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
INVO Fertility, Inc. (IVF) · 6 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, revenue growth. Concerns around market cap and operating margin. Significant fundamental concerns warrant caution or avoidance.
INVO Fertility, Inc. (IVF) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
Strong revenue growth at 22.60% annually
Supporting Valuation Data
INVO Fertility, Inc. (IVF) Areas to Watch (4)
Losing money on operations
Very expensive at 6.0x book value
Very low institutional interest at 9.44%
Micro-cap company with very limited liquidity and high volatility
INVO Fertility, Inc. (IVF) Detailed Analysis Report
Overall Assessment
This company scores 27/100 in our Smart Analysis, earning a F grade. Out of 6 metrics analyzed, 2 register as strengths (avg 9.0/10) while 4 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Revenue Growth. Valuation metrics including Price/Sales (0.69) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 22.60%.
The Bear Case
The primary concerns are Operating Margin, Price/Book, Institutional Own.. Some valuation metrics including Price/Book (5.97) suggest expensive pricing. Profitability pressure is visible in Operating Margin at -93.10%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at -93.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 22.60% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Operating Margin and Price/Book are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
IVF Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
IVF's Price-to-Sales ratio of 0.69x trades at a deep discount to its historical average of 12.31x (25th percentile). The current valuation is 99% below its historical high of 129.42x set in Dec 2015, and 477% above its historical low of 0.12x in Feb 2025.
WallStSmart Analysis Synopsis
Data-driven financial summary for INVO Fertility, Inc. (IVF) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
INVO Fertility, Inc. is a strong growth company balancing expansion with improving profitability. Revenue reached 7M with 23% growth year-over-year.
Key Findings
Free cash flow is -2M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can INVO Fertility, Inc. maintain 23%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact INVO Fertility, Inc..
Bottom Line
INVO Fertility, Inc. offers an attractive blend of growth (23% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About INVO Fertility, Inc.(IVF)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. The company is headquartered in Sarasota, Florida.